Back to Search
Start Over
2019-nCoV/COVID-19 - Approaches to Viral Vaccine Development and Preventive Measures.
- Source :
-
Journal of Pure & Applied Microbiology . Mar2020, Vol. 14 Issue 1, p25-29. 5p. - Publication Year :
- 2020
-
Abstract
- The severity assessment of COVID-19 and transmissibility of newly emerged novel-Coronavirus (2019-nCoV) can effectively help and support to quantify the ongoing pandemic risks. Among several epidemiological measures against COVID-19 severity, the case fatality risk (CFR) assessment is an important measure to track record the overall proportion/ratio of the cumulative number of infected patients with the known outcome (confirmed, recovered, or deceased). Considering the ongoing fatality rate, several case-based preventive measures, Coronavirus protein visualization, and approaches to viral vaccine development are discussed herein. The prompt identification of high-risk entities to confront the uncertainty in the risk of death using the approaches highlighted, herein, is of utmost requirement to tackle the current COVID-19 severity. Moreover, the protein visualization available at the viral surface/body can give further insight into the appropriate vaccine development. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 09737510
- Volume :
- 14
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Journal of Pure & Applied Microbiology
- Publication Type :
- Academic Journal
- Accession number :
- 143403043
- Full Text :
- https://doi.org/10.22207/JPAM.14.1.05